Authors: Men, R Wyatt, L Tokimatsu, I Arakaki, S Shameem, G Elkins, R Chanock, R Moss, B Lai, CJ

Citation: R. Men et al., Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge, VACCINE, 18(27), 2000, pp. 3113-3122

Authors: Zhu, YD Rota, P Wyatt, L Tamin, A Rozenblatt, S Lerche, N Moss, B Bellini, W McChesney, M

Citation: Yd. Zhu et al., Evaluation of recombinant vaccinia virus - Measles vaccines in infant rhesus macaques with preexisting measles antibody, VIROLOGY, 276(1), 2000, pp. 202-213

Authors: Seth, A Ourmanov, I Schmitz, JE Kuroda, MJ Lifton, MA Nickerson, CE Wyatt, L Carroll, M Moss, B Venzon, D Letvin, NL Hirsch, VM

Citation: A. Seth et al., Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge, J VIROLOGY, 74(6), 2000, pp. 2502-2509

Authors: Ourmanov, I Brown, CR Moss, B Carroll, M Wyatt, L Pletneva, L Goldstein, S Venzon, D Hirsch, VM

Citation: I. Ourmanov et al., Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV, J VIROLOGY, 74(6), 2000, pp. 2740-2751